Skip to main content
. 2015 Aug 5;15:311. doi: 10.1186/s12879-015-1064-z

Table 2.

Clinical manifestations, laboratory findings, and outcomes among 465 cellulitis cases

All (n = 465) Non-purulent group (n = 369) Purulent group (n = 96) P-value
Lower extremities involved (%) 364 (78.3) 304 (82.4) 60 (62.5) <0.001
Sepsis at admission (%) 127 (27.3) 103 (27.9) 24 (25.0) 0.568
WBC, mean 109/L (SD) 10.3 (4.9) 10.2 (5.0) 10.5 (4.8) 0.572
Hb (g/dL), mean (SD) 12.9 (2.2) 12.9 (2.2) 13.0 (2.3) 0.658
PLT/mm3 (SD) 200.6 (78.9) 195.0 (77.2) 221.9 (82) 0.003
Lactic acid (mmol/L), mean (SD) 1.8 (1.2) 1.8 (1.2) 1.9 (1.3) 0.917
Cr (mg/dL), mean (SD) 1.3 (1.7) 1.4 (1.9) 1.1 (0.7) 0.175
CK (U/L), mean (SD) 142.1 (343) 144.2 (368) 131.8 (165.9) 0.813
CRP (mg/dL), mean (SD) 6.3 (7.6) 6.3 (7.7) 6.3 (7.4) 0.993
GOT (IU/L), mean (range) 31.0 (23.6) 30.4 (19.8) 33.2 (34.4) 0.5
Albumin (g/dL), mean (SD) 3.1 (0.7) 3.1 (0.7) 3.2 (0.6) 0.71
Recurrence within 6 months (%) 57 (12.3) 54 (14.6) 3 (3.1) 0.001
Death within 30 days (%) 3 (0.6) 3 (0.8) 0 (0) 1.0
Length of stay, days (SD) 9 (6.5) 8 (5.8) 11 (8.1) 0.001
Duration of antimicrobial therapy, days (SD) 14 (9.7) 13 (9) 17 (12) 0.003

Data are number (%) of patients, unless otherwise indicated

CK creatine kinase, Cr creatinine, CRP C-reactive protein, GOT glutamate oxaloacetate transaminase, Hb hemoglobin, PLT platelet count, SD standard deviation